1. Lewis T (Oct 28, 2019) Scientific American, What we know about the possible carcinogen found in Zantac. Available: https://www.scientificamerican.com/article/what-we-know-about-the-possible-carcinogen-found-in-zantac/ . accessed 2023 Oct. 13.
2. (July 23, 2020) Status of ranitidine drugs in Canada [public advisory], Recalls and safety alerts (Health Canada, Ottawa) Available: https://recalls-rappels.canada.ca/en/alert-recall/status-ranitidine-drugs-canada . accessed 2023 Oct. 13.
3. (Dec 5, 2019) Statement from Janet Woodcock, MD, director of FDA’s Center for Drug Evaluation and Research, on impurities found in diabetes drugs outside the US [press release] (US Food and Drug Administration, Silver Spring (MD)) Available: https://www.fda.gov/news-events/press-announcements/statement-janet-woodcock-md-director-fdas-center-drug-evaluation-and-research-impurities-found . accessed 2023 Oct. 13.
4. (1978) Some N-nitroso compounds: IARC monographs on the evaluation of carcinogenic risk of chemicals to humans (International Agency for Research on Cancer, Lyon (FR)).
5. (Apr 29, 2019) Impurities found in certain angiotensin II receptor blocker (ARB) products, also known as sartans (Health Canada, Ottawa) Available: https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/angiotensin-receptor-blocker.html . accessed 2023 Feb. 23.